Home » Authors » Brady Huggett

Articles by Brady Huggett

Pharma Growing Biologics Work To Supplement Small Molecules

Nov. 8, 2006

By Brady Huggett

Pharma Growing Biologics Work To Supplement Small Molecules

Nov. 8, 2006

By Brady Huggett

Biotech Rides Wave Of M&A; Licensing Deals Remain Hot

Nov. 7, 2006

By Brady Huggett

Biotech Rides Wave Of M&A; Licensing Deals Remain Hot

Nov. 7, 2006

By Brady Huggett

Alteon Sees New Life For Alagebrium After Merger

Aug. 14, 2006

By Brady Huggett

Alteon Sees New Life For Alagebrium After Merger

Aug. 14, 2006

By Brady Huggett

Nasdaq In Lead, But Potential LSE Merger Raises Questions

July 19, 2006

By Brady Huggett

Nasdaq In Lead, But Potential LSE Merger Raises Questions

July 19, 2006

By Brady Huggett

Nasdaq In Lead, But Potential LSE Merger Raises Questions

July 14, 2006

By Brady Huggett

Nasdaq In Lead, But Potential LSE Merger Raises Questions

July 14, 2006

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...